3rd Annual Hope for the Future in Black Myeloma Virtual Roundtable

Name: 3rd Annual Hope for the Future in Black Myeloma Virtual Roundtable
Start: 2025-02-27T14:00:00-05:00
End: 2025-02-27T16:00:00-05:00

Feb 27, 2025

02:00PM - 04:00PM EST

Online Event

Overview

Building on the success of our previous roundtables, we are proud to present our third annual Black History Month event focusing on the critical intersection of multiple myeloma care and the Black community. Over the past two years, we've engaged in vital discussions about novel therapies, treatment accessibility, and the unique challenges facing Black myeloma patients, featuring renowned experts including Drs. Brandon Blue and Monique Hartley-Brown.

This year's roundtable continues our tradition of bringing together leading Black myeloma specialists to share their expertise and insights on the evolving landscape of myeloma treatment and care in the Black community. Our distinguished panel will explore:

- Latest developments in myeloma research and treatment specifically relevant to Black patients

- Updates on immunotherapy outcomes and accessibility since our previous discussions

- Progress made in addressing healthcare disparities identified in past roundtables

- Emerging treatment options and clinical trials

- Strategies for improving access to cutting-edge therapies in the Black community

Join us for this landmark event as we build upon our previous conversations about CAR-T therapy, bispecific T cell engagers (BiTE), and other innovative treatments while examining their evolving impact on Black myeloma patients. Our experts will assess the progress made since our first roundtable and outline the path forward for ensuring equitable access to revolutionary treatments.

This virtual event represents our ongoing commitment to addressing disparities in myeloma care and fostering hope through education, awareness, and expert dialogue. Don't miss this opportunity to be part of this important conversation about the future of Black myeloma health.

Together, we continue to build hope for the future of Black myeloma care.

Agenda

2:00 PM

Introductions

Valarie Traynham

Valarie introduces the agenda of the event and our featured speakers Dr. Ayo Fatoki, Dr. Monique Hartley-Brown, Dr. Brandon Blue and Dr. Shakira Grant.

2:05 PM

Presentation

Monique Hartley-Brown, MD

2:35 PM

Presentation

Brandon Blue, MD

3:05 PM

Questions and Answers

Audience

Type your questions in the chat and we will answer them!

Speakers & Moderators

Valarie Traynham

Valarie embarked on her myeloma journey back in 2015, and ever since she's been on a mission. As a resilient myeloma thriver, her passion lies in not just navigating her own path but also in illuminating the journey for others. With a steadfast commitment to understanding the intricacies of the disease, she champions education, shedding light on health inequities that often lurk in the shadows. Driven by a profound belief in fairness, Valarie tirelessly advocates for equitable access to top-tier healthcare, clinical trials, and tailored treatments. Her journey as a beacon of knowledge and support began when she assumed the role of a support group leader. Today, she continues to extend her hand as a myeloma coach, mentor angel, and the guiding force behind the Black Myeloma Health Community. Valarie's voice echoes far and wide as she fearlessly confronts the disparities faced by myeloma patients. Through collaborative efforts with healthcare providers, she strives to forge pathways to solutions, ensuring that every individual receives the care they deserve. Join Valarie on her journey of empowerment and advocacy as she lights the way toward a brighter, more equitable future in myeloma care.

Brandon Blue, MD

Brandon Blue, MD Assistant Member, Malignant Hematology Department H. Lee Moffitt Cancer Center & Research Institute Dr. Blue is an Assistant Member and Clinical Instructor in the Department of Malignant Hematology at Moffitt Cancer Center. He earned his MD from Meharry Medical College in Nashville, TN. He completed an Internal Medicine Residency in the Department of Medicine at Washington University School of Medicine and a Hematology/Oncology Fellowship at St. Louis University School of Medicine in St. Louis, Missouri. Dr. Blue completed a Blood and Marrow Transplant and Cellular Immunotherapy Fellowship at Moffitt Cancer Center. Dr. Blue’s clinical interests include treatment of plasma cell disorders and evaluation of patients pre and post stem cell and bone marrow transplant. His research interests include reducing health disparities and improving health outcomes for plasma cell dyscrasias.

Monique Hartley-Brown, MD

Dr. Hartley-Brown is an emerging leader in the field of Multiple Myeloma. She is an Associate Physician at Harvard Medical School and Assistant Professor & Medical Oncologist who specializes in treating patients with multiple myeloma. She practices clinical care at the Jerome Lipper Multiple Myeloma Center at Dana-Farber Cancer Institute. Multiple myeloma is an incurable cancer that affects Black Americans approximately twice more than Caucasians. Dr. Hartley-Brown has written several publications and has been a clinical research investigator for numerous clinical studies that has contributed to the advancement of clinical care for patients with multiple myeloma and plasma cell dyscrasias. As a Black female physician, she is dedicated to ensuring that the care for the myeloma community is equitable and affords all patients with myeloma an optimal level of care regardless of background, race or socioeconomic status.